Speakers

Jane Grogan

Chief Scientific Officer

Graphite Bio

Jeremy Waight

Scientific Director

GlaxoSmithKline

Marc Ballas

Vice President Oncology Clinical Development

GlaxoSmithKline

Kartik Krishnan

Vice President, Clinical Development

Arcus Biosciences

Sandhya Girish

Vice President Clinical Pharmacology

Gilead Sciences

Dhan Chand

Scientific Director, Head of Drug Discovery

Agenus

Eran Ophir

Vice President Research & Drug Discovery

Compugen Ltd.

Yvonne McGrath

Vice President R&D

iTeos Therapeutics

Gregory Driessens

Senior Director, Project Head

iTeos Therapeutics

Alyson Smith

Associate Director

Seattle Genetics

Sreeneeranj Kasichayanula

Senior Director Clinical Pharmacology

Gilead Sciences

David Hafler

Professor

Yale School of Medicine

Suba Krishnan

Senior Vice President Clinical Development

Mereo BioPharma

Taylor Schreiber

CEO

Shattuck Labs

Michael Lim

Chair of Neurosurgery

Stanford University

Vijay Kuchroo

Director Evergrande Center for Immunologic Diseases

Harvard Medical School and Brigam and Women's Hospital

Diwakar Davar

Assistant Professor of Medicine, Melanoma & Phase I Therapeutics

University of Pittsburgh Medical Center, Hillman Cancer Center

Pini Tsukerman

Chief Scientific Officer

Nectin Therapeutics Ltd.

Shyra Gardai

Executive Director

Seattle Genetics

Ann Kapoun

Senior Vice President Translational Research & Development

Mereo BioPharma

Nicole Joller

Assistant Professor

University of Zurich

Ahmed Tajmohamed

Researcher

Beacon Targeted Therapies

Farahnaz Forozan

President

Forozan OncoGen Consulting

Franziska Brauneck

Assistant Doctor

University Medical Center Hamburg-Eppendorf

Karina Yazdanbakhsh

Vice President and Director of Research Development

Lindsley F. Kimball Research Institute, New York Blood Centre

Tobias Bald

Professor of Tumorimmunobiology

University Hospital Bonn

Walter Fiedler

Associate Professor

University Medical Center Hamburg-Eppendorf